$PHVS 3 SEC Filings

Filed On	Filing
18 Mar 2026	Form 3: Glassman Robert, Director Holds 15,167 shares of Common Stock
18 Mar 2026	Form 3: Schikan Johannes Gerardus Christiaan Petrus, Director Holds 395,167 shares of Common Stock
18 Mar 2026	Form 3: Bjork Elisabeth, Director Holds 15,167 shares of Common Stock
18 Mar 2026	Form 3: Nassif David W., CFO / CLO Holds 123,925 shares of Common Stock
18 Mar 2026	Form 3: Abele Stefan Andreas, Chief Technical Ops Officer Holds 43,942 shares of Common Stock
18 Mar 2026	Form 3: Lesage Anne, Chief Early Development Holds 56,450 shares of Common Stock
18 Mar 2026	Form 3: Souverijns Wim, Chief Commercial Officer Holds 55,111 shares of Common Stock
18 Mar 2026	Form 3: Nijdam Anna, Principal Accounting Officer Holds 51,819 shares of Common Stock
18 Mar 2026	Form 3: Meeker David P, Director Holds 65,167 shares of Common Stock
18 Mar 2026	Form 3: Monges Viviane, Director Holds 14,654 shares of Common Stock
18 Mar 2026	Form 3: Lu Peng, Chief Medical Officer Holds 66,309 shares of Common Stock
18 Mar 2026	Form 3: Modig Berndt, Director Holds 165,417 shares of Common Stock
18 Mar 2026	Form 3: Deschoolmeester Annick, Chief Human Resources Officer Holds 92,553 shares of Common Stock

Comments